vs
Amarin Corp plc（AMRN）与合众银行（FSBC）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是Amarin Corp plc的1.0倍（$45.1M vs $45.1M），合众银行净利率更高（41.3% vs -23.3%，领先64.6%），过去两年合众银行的营收复合增速更高（21.3% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
AMRN vs FSBC — 直观对比
净利率更高
FSBC
高出64.6%
-23.3%
两年增速更快
FSBC
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $45.1M |
| 净利润 | $-10.5M | $18.6M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | — |
| 净利率 | -23.3% | 41.3% |
| 营收同比 | 7.0% | — |
| 净利润同比 | 33.0% | 42.0% |
| 每股收益（稀释后） | — | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNFSBC
| Q1 26 | $45.1M | $45.1M | ||
| Q4 25 | $49.2M | $43.5M | ||
| Q3 25 | $49.7M | $41.3M | ||
| Q2 25 | $72.7M | $38.3M | ||
| Q1 25 | $42.0M | $35.3M | ||
| Q4 24 | $62.3M | $35.2M | ||
| Q3 24 | $42.3M | $31.8M | ||
| Q2 24 | $67.5M | $30.7M |
净利润AMRNFSBC
| Q1 26 | $-10.5M | $18.6M | ||
| Q4 25 | $-1.2M | $17.6M | ||
| Q3 25 | $-7.7M | $16.3M | ||
| Q2 25 | $-14.1M | $14.5M | ||
| Q1 25 | $-15.7M | $13.1M | ||
| Q4 24 | $-48.6M | $13.3M | ||
| Q3 24 | $-25.1M | $10.9M | ||
| Q2 24 | $1.5M | $10.8M |
毛利率AMRNFSBC
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNFSBC
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 52.9% | ||
| Q3 25 | -22.4% | 53.8% | ||
| Q2 25 | -22.0% | 52.4% | ||
| Q1 25 | -39.9% | 52.0% | ||
| Q4 24 | -84.3% | 55.1% | ||
| Q3 24 | -59.5% | 48.0% | ||
| Q2 24 | -0.8% | 49.4% |
净利率AMRNFSBC
| Q1 26 | -23.3% | 41.3% | ||
| Q4 25 | -2.5% | 40.6% | ||
| Q3 25 | -15.6% | 39.6% | ||
| Q2 25 | -19.4% | 37.9% | ||
| Q1 25 | -37.4% | 37.1% | ||
| Q4 24 | -78.0% | 37.9% | ||
| Q3 24 | -59.4% | 34.4% | ||
| Q2 24 | 2.3% | 35.2% |
每股收益（稀释后）AMRNFSBC
| Q1 26 | — | $0.87 | ||
| Q4 25 | $0.00 | $0.83 | ||
| Q3 25 | $-0.02 | $0.77 | ||
| Q2 25 | $-0.03 | $0.68 | ||
| Q1 25 | $-0.04 | $0.62 | ||
| Q4 24 | $-0.12 | $0.61 | ||
| Q3 24 | $-0.06 | $0.52 | ||
| Q2 24 | $0.00 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $644.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $458.5M |
| 总资产 | $645.8M | $5.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNFSBC
| Q1 26 | $307.8M | $644.4M | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
股东权益AMRNFSBC
| Q1 26 | — | $458.5M | ||
| Q4 25 | $459.3M | $445.8M | ||
| Q3 25 | $458.9M | $431.3M | ||
| Q2 25 | $464.9M | $416.7M | ||
| Q1 25 | $473.7M | $406.5M | ||
| Q4 24 | $486.2M | $396.6M | ||
| Q3 24 | $531.4M | $389.9M | ||
| Q2 24 | $551.9M | $380.5M |
总资产AMRNFSBC
| Q1 26 | $645.8M | $5.0B | ||
| Q4 25 | $670.8M | $4.8B | ||
| Q3 25 | $659.8M | $4.6B | ||
| Q2 25 | $670.1M | $4.4B | ||
| Q1 25 | $655.7M | $4.2B | ||
| Q4 24 | $685.3M | $4.1B | ||
| Q3 24 | $750.6M | $3.9B | ||
| Q2 24 | $799.9M | $3.6B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
